Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

"To say that Brilacidin "has been proven to have antiviral activity, inhibiting the SARS-CoV-2 virus in Vero African green monkey kidney cells and Calu-3 human lung epithelial cells, and showing a synergistic inhibitory activity in combination with the antiviral remdesivir" and then to fail to note that "Brilacidin did not show a difference compared to placebo in reducing Time to Sustained Recovery Through Day 29",

"Obviously you are entitled to describe the paper as "news" just as I am free to describe it as "deceptive" but only one of us is correct. Would you like me to go over the facts again?

Then again you LR failed to say these facts- "certain patient subgroups did show treatment benefits of Brilacidin for that primary endpoint. For example, patients treated early from onset of symptoms achieved sustained recovery more quickly (Brilacidin 5-dose group vs pooled placebo, p=0.03).